assay of the eazyme in a fresh, previously not frozen Uver biopsy, homogenized in 0.25 M sucrose, revealed only about 29% of the activity of the same sample prepared in H 2 0 (mean * S.E. in three controls: 95.8% & 8.9) .
In this paper, we report our findings in a girl with GSD type Ib before and after treatment by portacaval shunt (PCS). It will be shown that, although the activity of G-6-Pase measured 3 years after PCS in a fresh liver biopsy homogenized in 0.25 M sucrose was severalfold lower than in the same sample homogenized in H20, an in vivo assay denoted a functional enzyme.
METHODS
Frozen liver biopsies were handled, and the concentration and structure of glycogen were determined as described by Hers (1 I). G-6-Pase and phosphorylase were assayed according to Hers and Van Hoof (12) . Acid a-glycosidase was measured by its ability to form glucose from maltose, and amylo-1.6-glucosidase by the incorporation of ["C]glucose into glycogen (12) . The activity of phosphorylase b kinase was determined as described by Lederer et al. (15) . Fructose-14-diphosphatase was measured according to Baker and Winegrad (3) . The measurements of the activity of G-6-Pase in fresh, unfrozen liver tissue were performed on supernatants obtained by centrifuging homogenates prepared either in H20 o r i n 0.25 M sucrosc for 10 min a t 600 X g. Investigations with p 3 H , U-'4C]glucose were performed as described by Hue and Hers (13) . The radioactivity injected amounted to 0.3 pCi of [U-'4C]glucose and I pCi of [2-3H] glucose per kg body weight.
The tests were performed after appropriate parental consent. Control liver samples were obtained by percutaneous biopsy from patients who required the procedure for other diagnostic purposes.
Speculation CASE REPORT
The higher than normal utilization of I2-'H; u14Clglucose D. L., born in July, 1963, suffered from recurrent attacks of observed after portacavd shunt in this patient suggests that hypoglycemia and convulsions since the first year of life. The besides the postulated defect of the microsomal g l u c o d~h o s -presence of hepatomegaly, lactic acidosis, and hypertriglyceridephate transport system (1919 other hitherto ~e x~l o r e d ~athoge-mia led to the suspicion of GSD type I. Liver biopsy revealed an netic mechanisms should be investigated, including the regulation increased glycogen content. Type Ib GSD was suggested by the of the synthesis of glucosebphos~hatase, to explain the impaired low normal activity of G-6-Pase, which reached 1.8 units/g of degradation of glycogen in type Ib glycogen storage disease.
liver, and the normal activity of other glycogenolytic enzymes and of fructose-l,6-diphosphatase, measured in homogenates prepared in H20 from previously frozen tissue (Table 1 ). An important I glycogen disease tGSD) has been subdivided growth retardation was obvious when the patient was first seen in into type la with deficiency of glucose-6-phosphatase (EC 3.1.3.9; our department in January, 1975. H~~ statural age was only 5 Gd-Pase), and type Ib with of the enzyme when years, her height being 109 cm. Weight was 22 kg; bone age was assayed in previously frozen tissue (18) . The finding in a patient 7 yea,. The liver was felt 15 cm below the costal ridge. Blood with type Ib of a very low activity of G-6-Pase in a fresh, unfrozen chemistry values after approximately 6 h of fasting are shown in liver biopsy, homogenized in isotonic sucrose, which was normal- Table 2 . In accordance with the diagnosis of G~~ type I, IV ized upon the addition of detergent, has led Narisawa er 01. (19) loading tests with fructose (0.5 g/kg body weight) and galactose to postulate a defect of the mi~rosomal glucose-6-pho~phate (G-6-(1 g/kg body weight) did not increase the glycemia. N~ significant P) transport system in the latter subtype, resulting in a non-increase in blood glucose was observed during the first 90 min functional enzyme. after the IV administration of glucagon (50 &kg body weight)
I Dedicated to Professor Andrea Pradcr on hi 60th birthday.
after 3 and 12 hr of fasting. However, a progressive increase in ' Range of five to seven determinations after 6 to 12 hr of fasting.
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blood glucose from 55 mg/dl up to 105 mg/dl after 180 min was recorded. Repeat liver biopsies confirmed the increase in glycogen content. Microscopic examination also revealed diffuse centrolobular steatosis. The structure of glycogen was normal (Table I) . The assay of phosphorylase b kinase and of amylo-1.6-glucosidase in the erythrocytes gave also normal values (not shown). Attempts to treat the patient at home with continuous night feeding remained unsuccessful, and it was decided to perform a PCS. As can be seen in Table 2 , preoperative continuous gastric feeding resulted in a marked improvement of blood chemistry values after I wk and was pursued during 3 wk before surgery. In accordance with the findings of Burr er>l. (5) . it was accompanied by a 3.5 cm decrease in liver size. The child underwent a terminolateral PCS on December 16, 1975 . The quadratus lobe had to be resected partially to avoid pressure on the anastomosis site. Recovery was uneventful apart from transitory ketotic hypoglycemia which was corrected by infusion of high amounts of glucose and bicarbonate. Such episodes have been observed after discontinuation of intragastric glucose drips (8, 16) . The patient was discharged 15 days after the surgical procedure with a regimen of frequent meals, including one night feeding. As apparent from Table 2 , PCS resulted in a marked improvement of the tolerance to fasting and of several other blood chemistry values. Figure 1 shows a decrease of glucose tolerance. accompanied by higher serum insulin levels. Blood glucagon and growth hormone concentrations (not shown) were not influenced by the PCS. Eighteen months after surgery, liver size had further decreased by 1.5 cm and remains unchanged since then. Most 33.3 kg during the same period. Repeat liver biopsies revealed a significant increase in the activity of G-6-Pase (Table I ) while steatosis was still present on microscopic examination.
SPECIAL STUDIES
In an attempt to elucidate the pathogenesis of the accumulation of glycogen in this patient, the following studies were performed, which could be realized only after the PCS had been established.
FUNCTIONAL TEST OF G-6-Paae ACTIVITY
The observation by Katz and Dunn (14) that the half-life of circulating glucose labeled on C-2 with "H was shorter than that of uniformly labeled [14C]glucose has been developed by Hue and Hers (13) into a functional in vivo diagnostic test of type I glycogenosis. Indeed, a selective loss of 2-"H occurs after the phosphorylation of glucose during the rapid interconversion of G-6-P and fructose-6-phosphate catalyzed by hexose-phosphate isomerase (Fig. 2) . The G-6-P can be hydrolyzed back to glucose. The loss of ,"H relative to I4C therefore requires an active G-6-Pase to be reflected in the circulating glucose. As a consequence, the "H/'4C ratio in blood glucose after the IV injection of 12-"H; U-14C]glucose, which declines to 50 to 70% of its initial value after I hr in control subjects. remains nearly constant in patients with a deficiency of G-6-Pase (Fig. 3) . This test was performed in our patient 5 months after PCS. The "H/I4C ratio in blood glucose decreased to 24% in 60 min, indicating a functional G-6-Pase. striking wasa growth spurt of I cm per month which was sustained for 18 months. No signs of puberty appeared before 2% years after
COMPARISON OF THE ACTIVITY OF G-6-Pase IN PREVIOUSLY FROZEN A N D UNFROZEN LIVER SAMPLES
PCS. when breast enlareement was noticed for the first time. ~h r d e years after PCS, ;he girl measured 138 cm (+29 cm), Because repeat assays of G-6-Pase in previously frozen liver corresponding with a statural age of 10 years, while bone age samples of the patient had given normal results, it was decided to matched chronological age. The weight increased from 22 kg to test the hypothesis of Narisawa er al. ( 19) by measuring the activity of the enzyme in an isotonic homogenate prepared from a fresh, unfrozen liver biopsy. These authors have postulated that the accumulation of glycogen in patients with GSD type Ib is caused by an impairment of the microsomal G-6-P transport system whereas the catalytic unit of the enzyme would be normal. This defect would not be revealed by the regular sampling technique. Indeed, freezing and thawing of the tissue, like other procedures resulting in a disruption of the microsomes (hypotonic media and detergents), would give access of the substrate to the catalytic unit. Measurement of the activity of G-6-Pase in a fresh, unfrozen specimen of the patient's liver, homogenized in 0.25 M sucrose. revealed only about 29% of the activity measured in the same sample prepared in H 2 0 (Table 3) and only 22% of the activity measured in the same biopsy after freezing. thawing, and homogenization in H20; this last activity reached 7.85 units/g of liver 
( Table I ). In contrast, the activity of G-6-Pase in the 0.25 M sucrose homogenates of fresh unfrozen liver from three control subjects was close to the activity measured in hypotonic preparations (Table 3) .
This observation provides additional information concerning the results of the surgical treatment of glycogen storage disease and also some further insight into the pathogenesis of subtype Ib. Both aspects will be considered separately.
TREATMENT OF GLYCOGEN STORAGE DISEASE WITH PORTAC'AVAL SHUNT
Since the first attempt by Starzl er al. (12) in 1965 to treat Hepatic GSD by PCS, a total of 26 children with t h~s disorder have been reported in the literature to have undergone this surgical procedure (4. 17). Patients with three kinds of enzyme defects have been treated: 17 with G-6-Pase deficiency (type I). 8 with amylo-1.6-glycosidase deficiency (type Ill), and one with phosphorylase deficiency. Three patients died shortly after the surgical procedure, and one patient died I Vl years after PCS apparently of a cause unrelated to either the portal diversion or the enzymatic defect. Most striking is the effect of PCS on growth velocity. which reached on the average 0.54 cm/month over 40 to 120 months in the 8 patients of Starzl er al. (21) and was accompanied by a parallel increase in bone age. Although the influence of the prepubertal period cannot be entirely excluded in our patient, a spectacular growth spurt was also recorded after PCS. reaching 29 cm in 3 years (0.8 cm/month). The effect on growth has been attributed to an increased delivery of insulin to peripheral tissues (7). due to the bypassing of the liver and resulting in an increased transport not only of glucose but also of amino acids across the cell membrane. Comparison of the results of the glucose tolerance tests in our patient before and after PCS. as well as the higher than normal utilization of [2-%I; U-'4C]glucose, demonstrated after surgery, are in favor of this interpretation. Decreases in the tendencyt~hypoglycemia, in liver size: and in the blood levels of lactic acid. cholesterol. trielvcerides. and uric acid have been noted " in nearly all patients reported and were also observed in this case.
Similar effects on growth, glucose tolerance, and other biochemical findings have been obtained by nocturnal gastric feeding (8 to 10) . This is certainly the treatment of choice in infants and small children; it is much less dangerous than PCS, although it requires skillful care. Indeed, sudden death has been reported with night gastric feeding when the administration of glucose stops abruptly (16) . In our patient, severe dwarfism had resulted in important psychologic repercussions, and trials with the gastric drip method had met with a refusal to pursue this treatment. Furthermore, the parents of the child were not able to cope with the relative complexity of the procedure. PCS was therefore performed as a treatment of last resort. In agreement with previous reports, continuous gastric feeding was performed preoperatively because it precludes the effect of PCS on the biochemical disturbances and particularly reverses the platelet dysfunction (5).
PATHOGENESIS OF TYPE Ib GLYCOGEN STORAGE DISEASE
Our findings bear a similarity with those of Narisawa el a/. (19) who found that a latent G-6-Pase could be demonstrated in a patient with GSD type Ib when an homogenate prepared in isotonic medium from fresh, previously unfrozen liver specimen was compared with an homogenate in which the microsomes had been disrupted. Whereas these authors added detergent to disrupt the microsomes, we have used an hypotonic medium. Our results are also in agreement with the proposal that G-6-Pase is a twocomponent complex, consisting of a G-6-P transport system which mediates the transfer of the glucose ester across the microsomal membrane and a catalytic component (I).
According to the hypothesis of Narisawa et a/. the accumulation of glycogen in type Ib GSD could be explained by a defect of this transport system, resulting in a nonfunctional G-6-Pase. Difficult to reconcile with this theory, however, is the marked decrease in the 3H/'4C ratio in blood glucose that indicates a functional G-6-Pase, which we observed after the injection of the [2-3H; U-'4C]hexose. It should nevertheless be remembered that this result was obtained 3 months after PCS and could, unfortunately, not be compared with data before surgery. The assay of G-6-Pase in sucrose was performed 3 years after PCS in our patient. It revealed as much as 29% of the activity of the enzyme, as compared with 7.8% in the child studied by Narisawa el a/. (19) . This higher activity of the enzyme, combined with the severalfold increase in the total amount of G-6-Pase in comparison with the value obtained before surgery (cfr. Table 1 the 3H/ C ratio in blood glucose. Accordingly, a reduction of the total amount of hepatic glycogen may be supposed after PCS because, although the concentration of the polysaccharide was not modified, a marked decrease in the size of the liver was recorded in t h e absence o f significant c h a n g e s o f t h e m o r p h o l o g i c steatosis.
The pronounced elevation in the total amount of G-6-Pase, noticed after PCS also raises the possibility of defect of the regulation of the synthesis of the enzyme and of the eventual influence of PCS on this process. Further observations before an eventual surgical treatment, involving the assay of the activity of G-6-Pase in vitro in fresh liver tissue, as well as in vivo by the measurement of the selective loss of 3H relative to I4C from [Z3H; U-'4glucose], and investigations of the regulation of the synthesis of G-6-Pase are clearly required to provide an insight in the pathogenesis of the accumulation of glycogen in patients with type Ib GSD, which are reported with increasing frequency (2, 6, 20) .
